When the time comes for a biopharma company to outsource its production, or to get support for the development of a new project, the pool of available CDMOs is quite deep. Everyone knows the big players, but maybe they are not suitable for everyone. They have proven expertise but as it happens with big organisations, they are usually not very flexible with increased indirect costs.
German CureVac N.V. has withdrawn its application for market approval of its COVID-19 vaccine candidate and will focus on the development of a second-generation vaccine.
Abstract: This white paper explores how to leverage hot melt extrusion solutions for small molecules.
James Brook, since June 2021 Head of Europe, Africa and Middle-East at Tigermed, about clinical research, and plans for his new role.
Beijing, China October 19, 2021 – Sino Biological, Inc. (Sino Biological or the Company), a biotechnology company which provides biological research reagents and related technical contract research services, will be featured on Worldwide Business with kathy ireland®, airing on FOX Business Network, Bloomberg International and other outlets as sponsored content. Hosted by business mogul Kathy Ireland, this award-winning television series takes an in-depth look at companies around the world currently impacting different sectors of business and society. Dr. Rob Burgess, Chief Business Officer for Sino Biological, will be interviewed.
The Whos Who of the biotech industry relies on Austria. Every second biotechnology company is located in the hotspot of Vienna, where a leading research centre the Campus Vienna BioCenter has emerged. Multinationals and startups benefit from an extensive value chain, from basic research to production and distribution. The national investment promotion agency Austrian Business Agency (ABA) is the first point of contact when making the leap into the Austrian market.
What started in 2013 as an attempt – to offer experts in analytical and microbiological quality control, contract laboratories, representatives from authorities and service providers an
industry event and a platform for exchanging knowledge and experience – has now become a firmly established date in the events calendar.
Bad news for Swiss drug discovery company Idorsia: Its Fabry disease hopeful lucerastat failed to reduce neuropathic pain in patients.
Since October, Dr. Gisèle Deblandre has strengthened the team of Cellbox Solutions GmbH in Norderstedt near Hamburg as Chief Scientific Officer.
Leading industry leaders, SMEs representatives and academia are joining in Vienna, Austria, at the 14th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB), from 6th to 7th of October, organised by EuropaBio and conference partners.